Detalhe da pesquisa
1.
Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical Response.
Prostate
; 76(14): 1257-70, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27324746
2.
T cell exhaustion and Interleukin 2 downregulation.
Cytokine
; 71(2): 339-47, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25516298
3.
Advanced generation anti-prostate specific membrane antigen designer T cells for prostate cancer immunotherapy.
Prostate
; 74(3): 286-96, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24174378
4.
Enhancement of flap survival and changes in angiogenic gene expression after AAV2-mediated VEGF gene transfer to rat ischemic flaps.
Wound Repair Regen
; 19(4): 498-504, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21649787
5.
Cell density plays a critical role in ex vivo expansion of T cells for adoptive immunotherapy.
J Biomed Biotechnol
; 2010: 386545, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20625484
6.
Human single-chain antibodies inhibit replication of human immunodeficiency virus type 1 (HIV-1).
AIDS Res Hum Retroviruses
; 21(10): 876-81, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16225415
7.
Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.
Clin Cancer Res
; 21(14): 3149-59, 2015 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25850950
8.
Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins.
Cancer Gene Ther
; 11(4): 297-306, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15002034
9.
Recombination-deletion between homologous cassettes in retrovirus is suppressed via a strategy of degenerate codon substitution.
Mol Ther Methods Clin Dev
; 1: 14022, 2014 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25419532
10.
Anti-HIV designer T cells progressively eradicate a latently infected cell line by sequentially inducing HIV reactivation then killing the newly gp120-positive cells.
Virology
; 446(1-2): 268-75, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24074590
11.
Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells.
Clin Cancer Res
; 18(21): 5949-60, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22966020
12.
Anti-GD3 chimeric sFv-CD28/T-cell receptor zeta designer T cells for treatment of metastatic melanoma and other neuroectodermal tumors.
Clin Cancer Res
; 16(10): 2769-80, 2010 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20460472
13.
T cell activation upon exposure to patient-derived tumor tissue: a functional assay to select patients for adoptive T cell therapy.
J Immunol Methods
; 359(1-2): 11-20, 2010 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-20460126
14.
Genetically engineered T cells as adoptive immunotherapy of cancer.
Cancer Chemother Biol Response Modif
; 20: 315-41, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12703212
15.
Anti-prostate specific membrane antigen designer T cells for prostate cancer therapy.
Prostate
; 61(1): 12-25, 2004 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15287090